Pulmonary Hemorrhage Clinical Trial
Official title:
Lung Ultrasound Safety in Humans
The purpose of this study is to investigate if diagnostic ultrasound as it is routinely
performed in humans causes lung hemorrhage significant enough to appear on thoracic CT. The
investigators' hypothesis is that diagnostic lung ultrasound will not cause lung hemorrhage
in humans. Damage to the lung in animal models has been shown to be mechanical rather than
thermal in nature and evidence suggests that this injury is likely not from inertial
cavitation but from alveolar resonance. Models of the alveolar resonance theory predict that
hemorrhage should not happen in adult human lungs if the ultrasound frequency is higher than
1.69 MHz and mechanical index (MI) is less than 1.9 which is maintained with standard
scanning protocol for thoracic ultrasound. A previous human study showed no gross
macroscopic lung hemorrhage in patients undergoing transesophageal echocardiography with
pressures of 2.4 MPa and MI 1.3 with exposure durations ranging 7-68 minutes.
The investigators propose to perform a routine lung ultrasound exam on patients who are
scheduled to undergo chest computed tomography evaluation for pulmonary embolus as part of
their routine care. The ultrasound will be performed immediately prior to CT imaging and
markers will be placed on the patients chest to ensure the correct lung tissue is being
evaluated. There will be two sham markers so the radiologist will be blinded to which tissue
had ultrasound applied and which did not. The CT scan will then be evaluated per routine and
also to see if there are signs of microscopic or macroscopic hemorrhage under the skin
markers.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | August 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - All patients greater than 18 years of age scheduled to receive chest tomography scans for pulmonary embolus. Exclusion Criteria: |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital |
United States,
Bruzzi JF, Rémy-Jardin M, Delhaye D, Teisseire A, Khalil C, Rémy J. Multi-detector row CT of hemoptysis. Radiographics. 2006 Jan-Feb;26(1):3-22. Review. — View Citation
Child SZ, Hartman CL, Schery LA, Carstensen EL. Lung damage from exposure to pulsed ultrasound. Ultrasound Med Biol. 1990;16(8):817-25. — View Citation
Jabaraj DJ, Jaafar MS. Theoretical calculation of resonant frequencies of the human alveolar wall and its implications in ultrasound-induced lung hemorrhage. Int J Bioscience Biochem Bioinformatics. 2013;3(1):5-9
Meltzer RS, Adsumelli R, Risher WH, Hicks GL Jr, Stern DH, Shah PM, Wojtczak JA, Lustik SJ, Gayeski TE, Shapiro JR, Carstensen EL. Lack of lung hemorrhage in humans after intraoperative transesophageal echocardiography with ultrasound exposure conditions similar to those causing lung hemorrhage in laboratory animals. J Am Soc Echocardiogr. 1998 Jan;11(1):57-60. — View Citation
Miller DL. Induction of pulmonary hemorrhage in rats during diagnostic ultrasound. Ultrasound Med Biol. 2012 Aug;38(8):1476-82. doi: 10.1016/j.ultrasmedbio.2012.04.004. Epub 2012 Jun 12. — View Citation
O'Brien WD Jr, Yang Y, Simpson DG, Frizzell LA, Miller RJ, Blue JP Jr, Zachary JF. Threshold estimation of ultrasound-induced lung hemorrhage in adult rabbits and comparison of thresholds in mice, rats, rabbits and pigs. Ultrasound Med Biol. 2006 Nov;32(11):1793-804. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Micro or macroscopic lung parenchymal hemorrhage | The investigators will perform the ultrasound just prior to chest computed tomography enrollment so that there is minimal time delay between the ultrasound performance and assessment of the lung parenchyma. | At enrollment | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05001607 -
A Novel Method of Lung Isolation Compared With Standard Methods in a Model of Massive Pulmonary Hemorrhage
|
N/A | |
Recruiting |
NCT02913365 -
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
|
N/A | |
Recruiting |
NCT05053867 -
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
|
Phase 3 | |
Completed |
NCT01860014 -
Comparison of Two Different Natural Surfactants in the Treatment of Pulmonary Hemorrhage
|
N/A | |
Completed |
NCT03676023 -
Tranexamic Acid Per Inhalation for Treatment of Pulmonary Hemorrhage in Pediatric Patients
|